About Daniel Frank
Form D filings for Aseko from 2011 to 2023 list Daniel Frank as director.
Daniel Frank reports to the SEC as a director of 1 public company: Molecular Insight Pharmaceuticals (MIPI).
Daniel Frank first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Frank in the role, so the role may have started earlier or lasted longer.
Aseko, Inc.
Director
2011 – 2023 · Atlanta, GA
Through Glytec, provides insulin management software to healthcare providers.
MI
Molecular Insight Pharmaceuticals, Inc.
Director
2007 – 2010 · Public company (MIPI)
Key Colleagues at Startups
The people Daniel Frank works with at each company, as listed on that company's latest Form D.
Aseko, Inc. · Form D/A, Aug 14, 2023
EF
Edmond Furlong
Executive officer and director
AM
Andrew Midler
Executive officer and director
SW
Stephen Wallack
Executive officer
PC
Patrick Cua
Director
DD
Deborah Dean
Director